Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002615960 | SCV003505909 | pathogenic | Jeune thoracic dystrophy | 2022-09-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with IFT80-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change creates a premature translational stop signal (p.Asn654Lysfs*5) in the IFT80 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT80 are known to be pathogenic (PMID: 21227999, 23339108, 29068549). |
Fulgent Genetics, |
RCV005034764 | SCV005660357 | likely pathogenic | Asphyxiating thoracic dystrophy 2 | 2024-06-14 | criteria provided, single submitter | clinical testing |